1,000
Participants
Start Date
September 30, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
December 31, 2026
Tirzepatide
The treatment group will receive the study medication (tirzepatide) for a 12 month period starting with a 2.5mg dose once a week.
Placebo
Participants in the control group will receive a placebo instead of active study medication for a 12 month period.
Schmidt Initiative for Long COVID
UNKNOWN
Scripps Translational Science Institute
OTHER